Health Bulletin 11/November/2023 Roshni Dhar11 Nov 2023 2:16 PM ISTHere are the top health stories for the day:NBE grants final opportunity for registration to 2021, 2022 batch traineesThe National Board of...
Eli Lilly bags USFDA nod for Zepbound injection for weight loss Ruchika Sharma9 Nov 2023 1:30 PM ISTZepbound should be used with a reduced-calorie diet and increased physical activity.
FDA approves injection Tirzepatide for chronic weight management Dr. Kamal Kant Kohli9 Nov 2023 11:45 AM ISTThe US Food And Drug Administration has approved injection tirzepatide (Zepbound) for weight management in adults on long term basis. Tirzepatide...
Tirzepatide bests Prandial Insulin as add-on option to basal Insulin for improving glycemic control among diabetics Dr. Kamal Kant Kohli5 Nov 2023 8:00 PM ISTA recent study reveals tirzepatide as a highly effective and safer alternative to prandial insulin for individuals with type 2 diabetes inadequately...
Tirzepatide after intensive lifestyle intervention leads to additional 21.1% weight loss in obese adults Dr. Kamal Kant Kohli26 Oct 2023 10:30 AM ISTUSA: A phase 3 trial showed that tirzepatide provided a substantial additional reduction in body weight in participants who had achieved >=5.0%...
Medical Bulletin 18/October/2023 Isra Zaman18 Oct 2023 3:00 PM ISTHere are the top medical news of the day:Is Diabetes drug Mounjaro also effective for weight loss? Nature Medicine Study sheds light! A recent...
Is Diabetes drug Mounjaro also effective for weight loss? Nature Medicine Study sheds light! Isra Zaman18 Oct 2023 9:00 AM ISTA recent double-blind, placebo-controlled trial has revealed that Tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like...
Tirzepatide equally effective for treating early and late onset type 2 diabetes Dr. Kamal Kant Kohli14 Oct 2023 11:15 AM ISTTirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to...
Medical Bulletin 27/September/2023 Isra Zaman27 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes A new...
Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes Isra Zaman27 Sept 2023 9:00 AM ISTA new meta-analysis of 22 studies, presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany,...
Tirzepatide found more effective for control of blood sugar and body weight than semaglutide Dr. Kamal Kant Kohli25 Sept 2023 11:45 AM ISTResearchers at Aristotle University of Thessaloniki, Thessaloniki, Greece have found in a new meta-analysis that tirzepatide is superior to...
Eli Lilly concludes acquisition of Versanis Bio Ruchika Sharma18 Aug 2023 5:14 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Versanis Bio. The acquisition expands...
